10^th World Congress and Exhibition on Antibiotics and Antibiotic Resistance February 13-14, 2023 London, UK

John J.S. Cadwell received his degree in pharmacology from the University of Miami in 1981. He spent additional time studying at the University of Nottingham and the National Institute of Medical Research at Mill Hill, outside of London. He served in various capacities in the biomedical research fields until 2000 when he was founder of FiberCell Systems Inc. a company specializing in the research and supply of hollow fiber bioreactors. He has over 10 publications in the field and three patents relating to hollow fiber systems and is considered a world expert in the field.

Cell culture technology, stem cells, numismatics, oenophilia, cerevisaphilia, rock art posters, gratefuldeadophilia.

Mario A Bianchet received his Ph.D. from The University of La Plata, Argentine, and performed Postdoctoral studies at Johns Hopkins School of Medicine, where he is now an Assistant Professor of Neurology since 2011. He has published 70 papers in reputed journals. As structural enzymologist and expert in ligand recognition, he has participated in several seminal structural and mechanistic studies of macromolecules and ligand/macromolecule interactions of biomedical interest. He has significant contributions to different fields, including bioenergetics: F1-ATPase, xenobiotic-response: NADPH:Quinone oxidoreductases, DNA-repair: Uracyl-Glycosylase/inhibitors, carbohydrate-recognition: animal lectins, and late-stage cell-wall biosynthesis: LD-transpeptidases and their complexes with substrates and carbapenems.

My research aims to understand essential relations between macromolecules’ structure and their mechanisms of action in biological processes involved in human diseases. With that goal I am applying diverse techniques and methods including x-ray scattering and diffraction, as well as computer modeling and simulation to elucidate these relations that will have a direct impact on the understanding, diagnosis, treatment and prevention of human diseases

Kenny L De Meirleir is an Emeritus Professor in Physiology, Pathophysiology and Medicine. He has examined, diagnosed and treated almost 20,000 ME/CFS patients in all 5 continents of the world. Currently his scientific and medical practices are situated in Belgium at Himmunitas and the Nevada Center for Biomedical Research at the University of Nevada (USA).

Physiology, Pathophysiology and Medicine

Dr. Filutowicz is from the Bacteriology Department of University of Wisconsin-Madison conceived the core technology. Start and Promotion Dates Assistant Professor: 1987 Associate Professor: 1993 Full Professor: 1999 Education M.S. 1975 University of Warsaw and Polish Academy of Sciences, Warsaw Ph.D. 1979 Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw Postdoctoral Research: University of California-San Diego Areas of Study "Reproductive cycle" and biology of plasmids, anti-microbial agents, bio-therapeutics Teaching Microbiology 470: Microbial Genetics & Molecular Machines

"Reproductive cycle" and biology of plasmids, anti-microbial agents, bio-therapeutics

Kevin Galalae is the world’s foremost independent authority on the globalization-depopulation axis around which the international system has revolved since the inception of the United Nations in 1945, and the first to expose and scientifically demonstrate the existence, methods and consequences of the Global Depopulation Policy. He is the founder and Director of the Center of Global Consciousness (CGC), which is dedicated to the eradication of all covert chemical, biological, psychosocial and economic methods of population control and to their replacement with overt population control legislation through a global replacement level fertility law.

covert chemical, biological and bacteriological methods, Causes and Consequences of the Global Depopulation Policy and Chemical and Biological Depopulation.

Gerald C. Hsu received an honorable PhD in mathematics and majored in engineering at MIT. He attended different universities over 17 years and studied seven academic disciplines. He has spent 20,000 hours in T2D research. First, he studied six metabolic diseases and food nutrition during 2010-2013, then conducted research during 2014-2018. His approach is “math-physics and quantitative medicine” based on mathematics, physics, engineering modeling, signal processing, computer science, big data analytics, statistics, machine learning, and AI. His main focus is on preventive medicine using prediction tools. He believes that the better the prediction, the more control you have.

• Math-physical medicine (quantitative medicine) • Chronic diseases (T2D) • Endocrinology • Metabolism & metabolic disorders

Dr. A C MATIN is Professor at Stanford University School of Medicine. Dr. Matin's laboratory studies improvment in prodrug cancer chemotherapy; genetic and protein engineering to improve biological processes, such as bioremediation; microbial biofilms; cellular resistance to antimicrobial agents; and microbial stress response. Recent progress of the laboratory is: The ChrR enzyme has been crystallized and new improved mutants were obtained by rational design. Magnetite genes were expressed in mammalian cells. PK/PD studies of CNOB/ChrR anticancer therapy were completed. A new paradigm was worked out of bacterial sensitivity to antibiotics. In collaboration with NASA (Moffett Field) a protocol was developed to test hypotheses for increased bacterial antibiotic resistance by microgavity during actual space flight on board a small satellite He is in the editorial board of five journals member and chair of several NIH review panels.

Translational cancer research, Bacterial antibiotic resistance, Genetic & Molecular Medicine.

Dr. Nassiri is a former Associate Dean of Global Health at the Michigan State University (MSU). He also served as MSU director of Institute of International Health. He is currently Professor of Pharmacology and Toxicology, Professor of Family and Community Medicine, and, lecturer in Global Health, Infectious Diseases and Tropical Medicine. He currently works on international public health issues and has expertise in global health. He has made contributions in various fields of medical sciences including clinical investigation and health education. On the basis of his extensive experience and expertise in HIV/AIDS, TB and antimicrobial resistance, he developed clinical research programs in Brazil, South Africa, Haiti, Dominican Republic and Mexico. He had served as editorial board member for the journal of HIV and AIDS Review. He is currently on editorial board member for AIDS Patient Care and STDs. Prof. Nassiri has delivered seminar presentations on Tropical Medicine, HIV/AIDS, TB, Global Health and public health interventions in numerous national and international conferences and workshops. He is internationally recognized for his work in the areas of building effective international partnerships particularly in global health, community health, clinical care capacity building, and technical assistance mechanism. He is the founder of Michigan State University Osteopathic and Primary Health Clinic in Merida, Yucatan, Mexico. He has developed academic and research partnership programs with Federal University of Para Institute of Tropical Medicine in Belem, Brazil.

Chemotherapy of Tropical Medicine and Infectious Diseases, HIV/AIDS, Antibiotic Resistance, and Global Health.